<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20220423054626N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-03-02</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>The efficacy of husband’s support on maternal anxiety and stress of pregnant women undergoing the amniocentesis</public_title>
      <acronym></acronym>
      <scientific_title>The effect of husband’s support on maternal anxiety and stress of pregnant women undergoing the amniocentesis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-03-12</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>90</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63181</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: Method: Randomized blocking based on PASS_11 software with 4 blocks
Random unit: All pregnant mothers who meet the study entry criteria.
Tools: Blocked closed packets based on software
Concealment: The sealed packets

 of the people that have been prepared using the PASS_11 software are selected at the same time as the mother enters the study. Based on the assigned number in each group, the people are assigned to two intervention and control groups, Blinding description: Those who evaluate the outcome.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Amniocentesis.</hc_freetext>
      <i_freetext>Intervention group: For the wives of pregnant women in the intervention group, a face-to-face briefing session will be held for 45 to 60 minutes, two to seven days before the amniocentesis. Stress and anxiety of pregnant women and the effect of their presence and support on their husbands in reducing their stress and anxiety level from the time of knowing about the procedure, during the procedure, post-amniocentesis care, how to respond and They will be given time to go to the centers to receive the result. They are also asked to be present with and support their spouses during the amniocentesis. This support will include both physical and psychological parts. In the physical support section, the man takes the pregnant mother's hand with one hand and caresses her with the other hand, facing the mother's face so that she does not see the amniocentesis. In the psychological support section, the man establishes eye contact with the pregnant mother and reminds her of a pleasant memory in order to take his wife's mind away from the sampling area, and the researcher controls and records all these cases through a checklist. In both groups, the amniocentesis will be the same. To do the amniocentesis, the person lies on a test bed and to minimize the risk of infection, the abdomen is disinfected using alcohol. An ultrasound doctor uses a sonography to determine the exact location of the bladder to minimize the risk of harm to the fetus. This may take up to 20 minutes. The doctor then inserts a long, thin needle into the bladder through the abdominal wall and, under ultrasound guidance, closely monitors the process. The doctor removes the required amount of amniotic fluid with a syringe and then removes the needle. Getting fluid may take a few minutes, but it usually takes less than 30 seconds. It is worth mentioning that Spielberg Anxiety Questionnaire, Depression, Anxiety and Stress Questionnaire DASS-21 (Stress Section)  by pregnant women in both groups were completed by self-report before and after amniocentesis. The spouse will be present with the pregnant mother while filling out the questionnaire.Also, all these things are done in the presence of the researcher..</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is Sampling has not started yet.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Fatemeh Salehi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ebne_Sina Street</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9137913199</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>Salehif951@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>MahinTafazoli</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Ebne_Sina Street</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9 913791319</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>tafazolim@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Gestational age: 15-18 weeks
Ability of reading and writing
couples Satisfaction for participation in the project
candidate of amniocentesis
Score 20-59 from the Spielberger Anxiety Questionnaire on the Manifest's Anxiety Scale (mild to moderate)
Obtain a stress score greater than 14 and less than 26 from the DASS-21 questionnaire</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of infertility and Pregnancy with assisted reproductive techniques
History of amniocentesis
Taking psychiatric drugs
History of mental illness and hospitalization due to mental health problems for at least the last 6 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Z36.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Encounter for antenatal screening for chromosomal anomalies</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: For the wives of pregnant women in the intervention group, a face-to-face briefing session will be held for 45 to 60 minutes, two to seven days before the amniocentesis. Stress and anxiety of pregnant women and the effect of their presence and support on their husbands in reducing their stress and anxiety level from the time of knowing about the procedure, during the procedure, post-amniocentesis care, how to respond and They will be given time to go to the centers to receive the result. They are also asked to be present with and support their spouses during the amniocentesis. This support will include both physical and psychological parts. In the physical support section, the man takes the pregnant mother's hand with one hand and caresses her with the other hand, facing the mother's face so that she does not see the amniocentesis. In the psychological support section, the man establishes eye contact with the pregnant mother and reminds her of a pleasant memory in order to take his wife's mind away from the sampling area, and the researcher controls and records all these cases through a checklist. In both groups, the amniocentesis will be the same. To do the amniocentesis, the person lies on a test bed and to minimize the risk of infection, the abdomen is disinfected using alcohol. An ultrasound doctor uses a sonography to determine the exact location of the bladder to minimize the risk of harm to the fetus. This may take up to 20 minutes. The doctor then inserts a long, thin needle into the bladder through the abdominal wall and, under ultrasound guidance, closely monitors the process. The doctor removes the required amount of amniotic fluid with a syringe and then removes the needle. Getting fluid may take a few minutes, but it usually takes less than 30 seconds. It is worth mentioning that Spielberg Anxiety Questionnaire, Depression, Anxiety and Stress Questionnaire DASS-21 (Stress Section)  by pregnant women in both groups were completed by self-report before and after amniocentesis. The spouse will be present with the pregnant mother while filling out the questionnaire.Also, all these things are done in the presence of the researcher.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pregnant mother anxiety level. Timepoint: At the beginning of the study and before and after amniocentesis. Method of measurement: Spielberger Anxiety Questionnaire - DOS21 Questionnaire - Spouse Supportive Behavior Checklist.</prim_outcome>
      <prim_outcome>Pregnant mother stress level. Timepoint: At the beginning of the study and before and after amniocentesis. Method of measurement: Anxiety and Depression Stress Questionnaire DASS 21.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-10-26</approval_date>
        <contact_name>Ethics committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>Ebne sina Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
